Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
Bubendorf L, Dafni U, Schöbel M, Finn SP, Tischler V, Sejda A, Marchetti A, Thunnissen E, Verbeken EK, Warth A, Sansano I, Cheney R, Speel EJM, Nonaka D, Monkhorst K, Hager H, Martorell M, Savic S, Kerr KM, Tan Q, Tsourti Z, Geiger TR, Kammler R, Schulze K, Das-Gupta A, Shames D, Peters S, Stahel RA; Lungscape Consortium. Bubendorf L, et al. Lung Cancer. 2017 Sep;111:143-149. doi: 10.1016/j.lungcan.2017.07.021. Epub 2017 Jul 22. Lung Cancer. 2017. PMID: 28838386
HER2 gene status in primary breast cancers and matched distant metastases.
Tapia C, Savic S, Wagner U, Schönegg R, Novotny H, Grilli B, Herzog M, Barascud AD, Zlobec I, Cathomas G, Terracciano L, Feichter G, Bubendorf L. Tapia C, et al. Among authors: bubendorf l. Breast Cancer Res. 2007;9(3):R31. doi: 10.1186/bcr1676. Breast Cancer Res. 2007. PMID: 17511881 Free PMC article.
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.
D'Addario G, Rauch D, Stupp R, Pless M, Stahel R, Mach N, Jost L, Widmer L, Tapia C, Bihl M, Mayer M, Ribi K, Lerch S, Bubendorf L, Betticher DC. D'Addario G, et al. Among authors: bubendorf l. Ann Oncol. 2008 Apr;19(4):739-45. doi: 10.1093/annonc/mdm564. Epub 2007 Dec 19. Ann Oncol. 2008. PMID: 18096565 Free article. Clinical Trial.
Risk factors for polyoma virus nephropathy.
Prince O, Savic S, Dickenmann M, Steiger J, Bubendorf L, Mihatsch MJ. Prince O, et al. Among authors: bubendorf l. Nephrol Dial Transplant. 2009 Mar;24(3):1024-33. doi: 10.1093/ndt/gfn671. Epub 2008 Dec 10. Nephrol Dial Transplant. 2009. PMID: 19073658 Free PMC article.
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T, Günther S, Zlobec I, Savic S, Sauter G, Moch H, Mattarelli G, Eichenberger T, Curschellas E, Rüfenacht H, Bachmann A, Gasser TC, Mihatsch MJ, Bubendorf L. Zellweger T, et al. Among authors: bubendorf l. Int J Cancer. 2009 May 1;124(9):2116-23. doi: 10.1002/ijc.24174. Int J Cancer. 2009. PMID: 19117060 Free article.
346 results